Camson is well positioned to tap the growing demand in this segment. It is also scouting partners in Brazil and Indonesia for setting up manufacturing facilities, where the company will transfer technologies on royalty/license basis.
A look at financials of the company show steady growth, and good balance sheet:
| FY2011 | FY2010 | FY2009 | FY2008 | |
| Figures in ` Crore | ||||
| Income | 99.14 | 79.98 | 49.91 | 41.91 |
| Net Profit | 22.03 | 13.66 | 8.11 | 7.79 |
| Reseves & Surplus | 53.32 | 26.29 | 15.85 | 8.06 |
| Share Capital | 18.13 | 16.05 | 13.70 | 9.80 |
| Debt | N.A | 1.00 | 1.11 | 1.83 |
The current valuation is pretty attractive. As on July 15, 2011 - the P/E ratio was around 8.7. The company has given around 20% return on equity.
In June 2011, SBI Magnum Fund purchased 607,125 shares of Camson Bio for Rs. 226.73 Crore and before that, 452,990 shares in March 2011. Again, signs of a good bet!
Overall, looks a solid mult-bagger small cap for the long term!
No comments:
Post a Comment